AOA Dx Featured in The Journal of Precision Medicine

AOA Dx Inc is proud to annouce that they were featured in “The Journal of Precision Medicine, titled “Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malginancies”. The paper was authored by AOA’s Chief Scientific Officer H. Uri Saragovi, PHD, AOA’s Co-Founder and Chief Business Officer Anna Milik Jeter and Samantha A. Yee, a PhD cancidate at UT San Antonio.